CLASS II Drug recall · Reported 31 Jul 2019 · FDA Enforcement Report

Double Tussin DM (Dextromethorphan Hbr 20 mg recalled by Pharma-Natural

Pharma-Natural is recalling Double Tussin DM (Dextromethorphan Hbr 20 mg, Guaifenesin 300 mg) in each teaspoon, distributed nationwide in the US. The recall was initiated on 21 Jun 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots remaining within expiry.
Quantity recalled500 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1498-2019
FDA event ID
83190
Recalling firm
Pharma-Natural, Miami Lakes, FL
Classification
Class II
Status
Terminated
Recall initiated
21 Jun 2019
FDA classified
23 Jul 2019
Reported
31 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

21 Jun 2019Recall initiated by company
23 Jul 2019Classified by FDA+32 days
31 Jul 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

DOUBLE TUSSIN DM (Dextromethorphan Hbr 20 mg, Guaifenesin 300 mg) in each 5ml teaspoon, 4 FL OZ (120 mL) bottle, Distributed by: Pamby Dist., Miami, FL 33414, NDC 63708-121-04.

Where it was distributed

Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.

Nationwide FloridaPuerto RicoTexas

Questions about this recall

Is Double Tussin DM (Dextromethorphan Hbr 20 mg, Guaifenesin 300 mg) in each teaspoon recalled?

Yes. Pharma-Natural recalled Double Tussin DM (Dextromethorphan Hbr 20 mg, Guaifenesin 300 mg) in each teaspoon on 21 Jun 2019. The recall is Class II and its status is Terminated. Recall number D-1498-2019.

Why was it recalled?

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Which lots are affected?

All lots remaining within expiry.

Where was it sold?

Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pharma-Natural

All 17